Pharma and Biotech IP USA 2020
October 8, 2020 - MA USIAM
elizabeth.peckham@lbresearch.com
Phone:02079406891
The life sciences are seeing developments in new technologies and undergoing a period of dramatic change and innovation, all of which are challenging traditional IP strategies and business models. IAM's inaugural Pharma and Biotech IP USA heads to Boston after four successful years in Europe bringing together leading in-house practitioners and expert counsel to explore next-generation strategies for protecting and exploiting cutting-edge innovation. Companies already confirmed to attend include: AbbVie Aerie Pharmaceuticals Axcella Bayer BIO Boston Scientific Bristol Myers Squibb Evelo Biosciences GlaxoSmithKline Lonza Merck NantWorks Novo Nordisk Pfizer Pieris Pharma Recursion Pharma Synlogic Thermo Fisher Scientific USPTO